RDY Historical Cash Flow
| RDY Stock | USD 13.60 0.39 2.79% |
Analysis of Dr Reddys cash flow over time is an excellent tool to project Dr Reddys Laboratories future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as End Period Cash Flow of 6.3 B or Change In Cash of 1.6 B as it is a great indicator of Dr Reddys ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Dr Reddys Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Dr Reddys Laboratories is a good buy for the upcoming year.
RDY |
About RDY Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in RDY balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which RDY's non-liquid assets can be easily converted into cash.
Dr Reddys Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Dr Reddys Laboratories to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Dr Reddys operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Dr Reddys Laboratories financial statement analysis. It represents the amount of money remaining after all of Dr Reddys Laboratories operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Dr Reddys' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Dr Reddys Laboratories current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. At this time, Dr Reddys' Net Borrowings is fairly stable compared to the past year. Change To Operating Activities is likely to rise to about 4.8 B in 2025, despite the fact that Change To Inventory is likely to grow to (15.8 B).
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 18.9B | 27.4B | 31.6B | 33.1B | Dividends Paid | 5.0B | 6.6B | 7.6B | 8.0B |
Dr Reddys cash flow statement Correlations
Click cells to compare fundamentals
Dr Reddys Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dr Reddys cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (9.9B) | (5.3B) | (2.7B) | (18.4B) | (16.6B) | (15.8B) | |
| Dividends Paid | 4.1B | 4.1B | 5.0B | 6.6B | 7.6B | 8.0B | |
| Capital Expenditures | 12.6B | 19.0B | 18.9B | 27.4B | 31.6B | 33.1B | |
| Total Cash From Operating Activities | 35.7B | 28.1B | 58.9B | 45.4B | 52.2B | 54.9B | |
| Net Income | 19.1B | 23.6B | 60.5B | 55.7B | 64.0B | 67.2B | |
| Total Cash From Financing Activities | (298M) | (2.4B) | (26.9B) | (3.8B) | (3.4B) | (3.6B) | |
| End Period Cash Flow | 14.8B | 14.9B | 5.8B | 7.1B | 8.2B | 6.3B | |
| Change In Cash | 12.9B | 32M | (9.1B) | 1.3B | 1.5B | 1.6B | |
| Stock Based Compensation | 584M | 592M | 397M | 821M | 738.9M | 702.0M | |
| Free Cash Flow | 23.1B | 9.1B | 40.0B | 18.0B | 20.7B | 21.7B | |
| Change In Working Capital | (8.3B) | (13.9B) | (7.9B) | (20.2B) | (18.2B) | (17.3B) | |
| Begin Period Cash Flow | 2.0B | 14.8B | 14.9B | 5.8B | 6.6B | 7.2B | |
| Other Cashflows From Financing Activities | 9.3B | 2.2B | (21.2B) | 3.2B | 2.9B | 2.8B | |
| Depreciation | 12.8B | 11.8B | 12.5B | 14.8B | 17.1B | 17.9B | |
| Other Non Cash Items | 2.3B | (2.7B) | (22.0B) | (21.9B) | (25.2B) | (23.9B) | |
| Change To Netincome | (4.1B) | 5.4B | 12.0B | 6.6B | 7.6B | 8.0B | |
| Change To Liabilities | 398M | 1.6B | 2.9B | 4.4B | 5.1B | 5.3B | |
| Change To Account Receivables | 2.1B | (17.0B) | (5.8B) | (8.1B) | (7.2B) | (6.9B) | |
| Sale Purchase Of Stock | (474M) | (1.2B) | 334M | 368M | 331.2M | 314.6M | |
| Other Cashflows From Investing Activities | 1.2B | 873M | (30.1B) | (8.2B) | (7.3B) | (7.0B) | |
| Total Cashflows From Investing Activities | (4.9B) | (22.7B) | (26.4B) | (41.4B) | (37.2B) | (35.4B) | |
| Investments | 4.1B | (11.2B) | (41.4B) | (40.3B) | (36.3B) | (34.4B) | |
| Net Borrowings | (15.2B) | (19.2B) | 6.1B | 2.7B | 2.5B | 2.6B | |
| Change To Operating Activities | 4.1B | 4.8B | (3.3B) | 4.0B | 4.6B | 4.8B | |
| Issuance Of Capital Stock | 269M | 334M | 368M | 805M | 925.8M | 972.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for RDY Stock Analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.